Research Topics
| David M TaylorSummaryAffiliation: Institute of Psychiatry Country: UK Publications
|
Detail Information
Publications
Prior antipsychotic prescribing in patients currently receiving clozapine: a case note reviewDavid M Taylor
Maudsley Hospital, London, United Kingdom
J Clin Psychiatry 64:30-4. 2003..It is thought that only clozapine is likely to be effective in such cases and that other drugs are ineffective. We sought to discover prior patterns of antipsychotic prescribing in schizophrenic patients eventually prescribed clozapine...
Prospective 6-month follow-up of patients prescribed risperidone long-acting injection: factors predicting favourable outcomeDavid M Taylor
Pharmacy Department, Maudsley Hospital, London, UK
Int J Neuropsychopharmacol 9:685-94. 2006..61, p=0.001). Overall outcome of RLAI treatment is moderately good but better still when prescribed because of prior poor adherence and for more elderly patients. RLAI is less suitable for those who have previously received clozapine...
Risperidone long-acting injection: a prospective 3-year analysis of its use in clinical practiceDavid M Taylor
Pharmacy Department, Maudsley Hospital, London, UK
J Clin Psychiatry 70:196-200. 2009..To evaluate outcomes of clinical use of risperidone long-acting injection (RLAI) and determine factors predicting continuation with treatment...
Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patientsDavid M Taylor
Pharmacy Department, Maudsley Hospital, London, United Kingdom
J Clin Psychiatry 65:1076-83. 2004..The use of risperidone long-acting injection (RLAI) is reasonably well supported by controlled studies. Little is known about treatment outcomes in patients receiving RLAI in clinical practice...
Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysisDavid M Taylor
Maudsley Hospital, Denmark Hill, London, UK
J Clin Psychiatry 64:589-97. 2003..This study was designed as a cost analysis study comparing costs and basic clinical outcomes of treatment with risperidone or olanzapine in a naturalistic setting...
Outcome following clozapine discontinuation: a retrospective analysisJames M Atkinson
South London and Maudsley National Health Service NHS Trust, Pharmacy Department, Maudsley Hospital, London, United Kingdom
J Clin Psychiatry 68:1027-30. 2007..Our aim was to establish medium-term outcome in patients stopping clozapine in normal clinical practice...
Plasma concentrations of quetiapine, N-desalkylquetiapine, o-desalkylquetiapine, 7-hydroxyquetiapine, and quetiapine sulfoxide in relation to quetiapine dose, formulation, and other factorsDanielle S Fisher
Toxicology Unit, Department of Clinical Biochemistry, Bessemer Wing, King s College Hospital NHS Foundation Trust, London, United Kingdom
Ther Drug Monit 34:415-21. 2012....
Prognostic indicators for early discontinuation of risperidone long-acting injectionMaxine X Patel
Division of Psychological Medicine, Institute of Psychiatry and GKT School of Medicine, De Crespigny Park, London, UK
Int Clin Psychopharmacol 19:233-9. 2004..RLAI discontinuation is high early on but subsequently tapers off. Preceding antipsychotic type (depot versus oral) is a stronger prognostic indicator than treatment refractoriness for RLAI discontinuation...
A UK audit of screening for the metabolic side effects of antipsychotics in community patientsThomas R E Barnes
Department of Psychological Medicine, Imperial College Faculty of Medicine, Charing Cross Campus, London W6 8RP, UK
Schizophr Bull 33:1397-403. 2007....
Prolongation of QTc interval and antipsychoticsDavid M Taylor
Am J Psychiatry 159:1062; author reply 1064. 2002
